European Commission still considering EMEA role in device regulation
This article was originally published in RAJ Devices
Executive Summary
Despite stakeholder opposition, the European Commission says it has not ruled out involving the European Medicines Agency in the evaluation of the highest-risk medical devices – though it does not intend to introduce a premarket authorisation requirement for these products1.